Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double-masked, Methylprednisolone-control, Efficacy and Safety Study of 99Tc-MDP for Thyroid Associated Ophthalmopathy.

NCT03948191 is registered in ClinicalTrials.gov with Dalian University as lead sponsor.

NCT NCT03948191
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03948191 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double-masked, Methylprednisolone-control, Efficacy and Safety Study of 99Tc-MDP for Thyroid Associated Ophthalmopathy.
Lead sponsor
Dalian University
Phase
Phase 4
Overall status
Completed
Start date
October 16, 2017
Completion date
March 31, 2019
Enrollment
50 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

thyroid-associated ophthalmopathy